Articles & Resources

Market Trends

Below is a collection of articles, resources and stories from the Invetech team and industry experts, sharing their knowledge, experiences and advice on product development and market trends.

Market Trends

Clear filter

Driving Down Costs of Autologous Cell Therapy Manufacturing

Panelists from Acepodia, Celyad and SOTIO discuss how cell therapies are impacted by the high cost of manufacturing and share their insights on ways to drive down costs.

How COVID is Accelerating Multi-Drug Resistant Infections with Selux Dx

In this episode of Spilling the Tea, we talk with Steve Lufkin of Selux Diagnostics about building a company culture during a pandemic, changes in the antibiotic susceptibility testing (AST) market and the current fundraising environment.

The Future of Complex POC Tests with MDC Associates

In the first episode of our new “Spilling the Tea” interview series, we talk with Joen Johansen of MDC Associates about government and private partnerships and the future of complex POC tests.

Diagnostic Product Development in a Post-Pandemic Era – New and Emerging Trends

Post COVID-19, accelerated development timelines, flexible manufacturing and the elevated role of the supply chain will be product development best practices.

Commercializing Disruptive Technologies in Advanced Therapies

From the back of the napkin to the bedside: Panelists from CUTISS, Humacyte and TreeFrog Therapeutics share their inspirational journeys commercializing disruptive technologies

The Case for Leveraging the Cloud in Point of Care Device Development

How smart, connected Point of Care devices improve efficiencies, reduce development costs and provide competitive advantage through differentiation.

Emergency Use Authorization: How IVD Developers Can Use the EUA to Address COVID-19

Watch our interview with Fran White of MDC Associates on using the EUA for COVID-19 testing to fast track approval, what’s required by the FDA and how to plan for an eventual 510(k).

Detecting Coronavirus at the Point of Care – In Search of Bold Breakthroughs

In the fight against the Coronavirus pandemic, rapid detection of the disease is key. Point of Care diagnostics can rise to the challenge by providing accelerated time to result at the point of need.

Got Approval… Now What? Meeting Cell Therapy Market Demand

Panelists from bluebird bio, DiscGenics and Proteus, LLC share their vision for commercial manufacturing of cell therapies.

Drivers for Utilizing Cloud Solutions in POCT Device Development

Leveraging cloud solutions for Point of Care (POC) devices can significantly reduce development time and instrument cost while adding more diagnostic capabilities.

Navigating the Cost and Time of Cell Therapy Manufacturing Process Automation

In this article, we discuss available devices and technology developments for cell therapy products in preclinical, clinical and early commercialization phases.

Avoiding the Potholes Along the Pathway to Commercial Cell Therapies

Panelists from Cell Therapies, Duke University and Fate Therapeutics discuss how they envision the road ahead for some of the biggest challenges in cell therapy manufacturing.